Foreign businesses, a top Chinese official said in March, “are not foreigners, but family.” Then came a crackdown on firms with foreign ties.
Category: Eli Lilly and Company
-
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The New York Times – Business:The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
Sanofi Plans to Cut the Price of Insulin
The New York Times – Business:The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
-
Novo Nordisk Says It Will Slash the Price of Insulin
The New York Times – Business:The company’s decision follows a similar move by its rival, Eli Lilly, this month.
-
Eli Lilly Says It Will Cut the Price of Insulin
The New York Times – Business:The company said it would cap the monthly out-of-pocket cost of the diabetes drug at $35.